<p>Kangji Medical Holdings Ltd. has announced that on 12 November 2025, J.P. Morgan Securities PLC, a related party connected with the Offeror, sold 2,095,000 shares through hedging of Delta 1 products created as a result of wholly unsolicited client-driven orders. The total amount received from the sale was $19,226,382.75. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kangji Medical Holdings Ltd. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

09997

<p>J.P. Morgan Securities PLC sold 2,095,000 shares of Kangji Medical Holdings Ltd. on November 12, 2025, through hedging of Delta 1 products, resulting in a total amount of $19,226,382.75. This transaction was driven by unsolicited client orders. Kangji Medical published the original content on November 13, 2025, and is responsible for the information provided.</p>

J.P. Morgan Sells 2.1 Million Kangji Medical Shares in Privatisation Deal